Abstract
We report 8 cases of coccidioidomycosis associated with ruxolitinib treatment. Among 135 patients living in the coccidioidal-endemic region receiving ruxolitinib, 5 cases were diagnosed after starting and 4 had extrathoracic dissemination. Periodic serological screening while on ruxolitinib is warranted for patients residing in the coccidioidal-endemic region.
| Original language | English (US) |
|---|---|
| Article number | ofaa167 |
| Journal | Open Forum Infectious Diseases |
| Volume | 7 |
| Issue number | 6 |
| DOIs | |
| State | Published - May 19 2020 |
Keywords
- coccidioidomycosis
- fungal infections
- immunocompromised host
- ruxolitinib
ASJC Scopus subject areas
- Oncology
- Infectious Diseases